This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koch, W. Articles by Kastrati, A. Search for Related Content PubMed PubMed Citation Articles by Koch, W. Articles by Kastrati, A.

Angiotensin I–converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene

^* Deutsches Herzzentrum München and 1. Medizinische Klinik rechts der Isar, Technische Universität München, Munich, Germany

View larger version (16K): [in a new window]   Figure 1 Bar graph showing the incidences of angiographic restenosis (diameter stenosis 50% at six-month follow-up angiography) and clinical restenosis (need for target vessel revascularization due to symptoms or signs of ischemia in the presence of angiographic restenosis at the stented site over one year after stent placement) in patients treated with angiotensin I–converting enzyme (ACE) inhibitors (solid bars) and those not treated with ACE inhibitors (open bars).